FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Plenary + Drugs Day 1

FDA’s Rare Disease Day 2026 – An Event for Patients

FDA Expert Panel on Food Allergies

Roundtable on PMTA Submissions for ENDS Products

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 1

FDA Grand Rounds - Advancing Real World Evidence in FDA Regulatory Decision Making

FDA Grand Rounds - Postmarket Regulation of Cosmetic Products: The Who, What, When, Why, and How

FDA Grand Rounds - Adopting Large Language Models for Regulatory Review

Conversations on Cancer – Perspectives on Cancer Care Decision-Making Among Older Adults

FDA Clinical Investigator Training Course (CITC) 2023, Day 1 – Part 1

FDA's Public Meeting on Food Allergen Thresholds - 02/18/2026

FDA Regulatory Education for Industry (REdI) – Devices and Biologics Track

FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

January 22, 2026: Tobacco Products Scientific Advisory Committee Meeting

FDA Grand Rounds - Anti biofilm Technologies for Enhancing the Safety of Medical Device Surfaces

REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2)

FDA Grand Rounds - Statistical Considerations for Drug Development in Rare Disease

FDA Direct: Combating Rare Diseases at the FDA

Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020

Clinical Investigators Training Course 2023 - Day 1

FDA-USP-AAM | D1S3 - Industry’s Engagement in USP’s Standards-Setting Process